156 related articles for article (PubMed ID: 37217924)
1. Fractionated stereotactic radiotherapy of brain metastases: results of a retrospective study.
Gruber I; Stark P; Weidner K; Treutwein M; Koelbl O
Radiat Oncol; 2023 May; 18(1):85. PubMed ID: 37217924
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic radiosurgery of brain metastases: a retrospective study.
Gruber I; Weidner K; Treutwein M; Koelbl O
Radiat Oncol; 2023 Dec; 18(1):202. PubMed ID: 38115009
[TBL] [Abstract][Full Text] [Related]
3. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
[TBL] [Abstract][Full Text] [Related]
4. Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment.
Tuleasca C; Negretti L; Faouzi M; Magaddino V; Gevaert T; von Elm E; Levivier M
J Neurosurg; 2018 Feb; 128(2):352-361. PubMed ID: 28338441
[TBL] [Abstract][Full Text] [Related]
5. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
6. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
7. The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy.
Davis JN; Medbery C; Sharma S; Danish A; Mahadevan A
Radiat Oncol; 2013 Nov; 8():275. PubMed ID: 24274599
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery for intraventricular brain metastases.
Farnia B; Voong KR; Brown PD; Allen PK; Guha-Thakurta N; Prabhu SS; Rao G; Wang Q; Zhao Z; Mahajan A
J Neurosurg; 2014 Dec; 121 Suppl():26-34. PubMed ID: 25434934
[TBL] [Abstract][Full Text] [Related]
9. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
10. Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.
Mohammadi AM; Schroeder JL; Angelov L; Chao ST; Murphy ES; Yu JS; Neyman G; Jia X; Suh JH; Barnett GH; Vogelbaum MA
J Neurosurg; 2017 Mar; 126(3):735-743. PubMed ID: 27231978
[TBL] [Abstract][Full Text] [Related]
11. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases.
Lwu S; Goetz P; Monsalves E; Aryaee M; Ebinu J; Laperriere N; Menard C; Chung C; Millar BA; Kulkarni AV; Bernstein M; Zadeh G
Oncol Rep; 2013 Feb; 29(2):407-12. PubMed ID: 23151681
[TBL] [Abstract][Full Text] [Related]
13. Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patients.
Lehrer EJ; Ahluwalia MS; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Fakhoury KR; Rusthoven CG; Mathieu D; Trudel C; Malouff TD; Ruiz-Garcia H; Bonney P; Hwang L; Yu C; Zada G; Patel S; Deibert CP; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Jones BM; Green S; Sheehan JP; Trifiletti DM
J Neurosurg; 2023 May; 138(5):1178-1187. PubMed ID: 36115055
[TBL] [Abstract][Full Text] [Related]
14. [Hypofractionated stereotactic radiotherapy for brain metastases].
Schlienger M; Nataf F; Huguet F; Pene F; Foulquier JN; Orthuon A; Roux FX; Touboul E
Cancer Radiother; 2010 Apr; 14(2):119-27. PubMed ID: 20004125
[TBL] [Abstract][Full Text] [Related]
15. Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma.
Ikushima H; Tokuuye K; Sumi M; Kagami Y; Murayama S; Ikeda H; Tanaka M; Oyama H; Shibui S; Nomura K
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1389-93. PubMed ID: 11121638
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases.
Fokas E; Henzel M; Surber G; Kleinert G; Hamm K; Engenhart-Cabillic R
J Neurooncol; 2012 Aug; 109(1):91-8. PubMed ID: 22528795
[TBL] [Abstract][Full Text] [Related]
17. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
18. Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent.
Buglione M; Jereczek-Fossa BA; Bonù ML; Franceschini D; Fodor A; Zanetti IB; Gerardi MA; Borghetti P; Tomasini D; Di Muzio NG; Oneta O; Scorsetti M; Franzese C; Romanelli P; Catalano G; Dell'Oca I; Beltramo G; Ivaldi GB; Laudati A; Magrini SM; Antognoni P;
Lung Cancer; 2020 Mar; 141():1-8. PubMed ID: 31926440
[TBL] [Abstract][Full Text] [Related]
19. Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma.
Hara W; Tran P; Li G; Su Z; Puataweepong P; Adler JR; Soltys SG; Chang SD; Gibbs IC
Neurosurgery; 2009 Feb; 64(2 Suppl):A26-32. PubMed ID: 19165071
[TBL] [Abstract][Full Text] [Related]
20. Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy: outcomes and predictors of survival.
Sallabanda M; García-Berrocal MI; Romero J; García-Jarabo V; Expósito MJ; Rincón DF; Zapata I; Magallón MR
Clin Transl Oncol; 2020 Oct; 22(10):1809-1817. PubMed ID: 32124243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]